Description:
Oragenics, Inc. is a biotechnology firm headquartered in Tampa, Florida, dedicated to the development of innovative therapies and antibiotics targeting infectious diseases, particularly those caused by antibiotic-resistant bacteria. The company leverages its proprietary technologies to create novel drug candidates aimed at addressing pressing healthcare challenges. Committed to advancing public health, Oragenics is strategically enhancing its pipeline through partnerships and research initiatives, positioning itself as a key player in the global fight against infectious diseases and improving treatment options.
Address:
1990 MAIN STREET, SARASOTA, FL, UNITED STATES, 34236
Fiscal year end:
December
Market capitalization:
$4.51 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-100%
How much will you get:
$0
Prices dates:
30-10-2015: $23,940.00 and 31-10-2025: $1.23